District of Columbia v. Lynham

16 App. D.C. 85, 1900 U.S. App. LEXIS 5275
CourtCourt of Appeals for the D.C. Circuit
DecidedFebruary 7, 1900
DocketNo. 943
StatusPublished

This text of 16 App. D.C. 85 (District of Columbia v. Lynham) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
District of Columbia v. Lynham, 16 App. D.C. 85, 1900 U.S. App. LEXIS 5275 (D.C. Cir. 1900).

Opinion

Mr. Chief Justice Alvey

delivered the opinion of the Court:

This case comes from the Police Court of this District on writ of error, and the question presented is, whether the act charged against the defendant in error, Waddie E. Ljmham, was a violation of the act of Congress of February 17, 1898, entitled “An act relating to the adulteration of foods and drugs in the District of Columbia.”

The defendant in the court below was charged by information, with selling a certain drug, to wit, Hoffman’s Anodyne,” the same not being of the strength, quality and purity, as laid down and required by the United States Pharmacopoeia, contrary to the act of Congress.

[86]*86The defendant pleaded not guilty, and was tried by a jury, and was acquitted. The District of Columbia brings up the case on writ of error.

The pharmacopoeia referred to in the act of Congress, and in the information against the defendant, as furnishing tlie standard for testing drugs, is a book of authoritative directions for the selection and preparation of substances to be used as medicines, including a list of the articles of the materia medica, with their character and tests. It is said that almost every civilized country of importance has its own pharmacopoeia. The pharmacopoeia of the United States is recognized by statute, and is drawn up by a national convention of delegates from medical societies and universities, and is revised, or intended to be revised, every ten years, and is considered an authoritative standard for determining the composition of drugs. The present current edition is that of 1890.

It appears by the bill of exceptions taken at the trial, that the defendant, a druggist doing business in this city, sold to one Lynch a small bottle of “Hoffman’s Anodyne,” which, upon analysis by the chemist for the Health Office of the District of Columbia, was found to contain no ethereal oil, a necessary ingredient thereof, according to the United States pharmacopoeia. The defendant claimed, and he insisted upon the fact as a defense to the prosecution, that he had sold the anodyne to Lynch in the condition he received it from the manufacturer, without taking anything therefrom or adding anything thereto; “that he changed the drug when he received it into a bottle when he sold it to Lynch. That the ingredients in Hoffman’s Anodyne were of such a character that the ethereal oil speedily disintegrated into sulphuric acid and alcohol, and that such disintegration frequently occurred before the Hoffman’s Anodyne had reached the druggist from the manufacturer and without the bottle having been uncorked.”

The prosecution showed in rebuttal, that Hoffman’s [87]*87Anodyne would remain in perfect condition for two or three years; and then read in evidence from the United States Pharmacopoeia, edition of 1890, and official, the composition of Hoffman’s Anodyne, as follows:

Spiritus JEtheris Compositus.

Compound Spirit of Ether. (Hoffman’s Anodyne.) Ether, three hundred and twenty-five cubic centimeters.......;............................................. 325cc

Alcohol, six hundred and fifty cubic centimeters... 650cc

Ethereal oil, twenty-five cubic centimeters.......... 25cc

To make one thousand cubic centimeters...... l,000cc

Mix them.

At the close of the evidence, the court, at the instance of the defendant, instructed the jury, that if they found that any of the ingredients of Hoffman’s Anodyne was of such a nature that it would speedily disappear by evaporation or would disintegrate into alcohol and sulphuric acid; and that without knowledge on the part of the defendant, said ingredients or any of them had disappeared by evaporation or disintegration, then the jury should acquit the defendant.

In giving such instruction we think there was manifest error. Indeed, it is plainly in contravention of the reason and spirit of the act of Congress, if not of the very letter of the statute. It is true, the act is a stringent one in its provisions, but without such stringency it would be simply ineffectual as a means to accomplish the object proposed. To fully appreciate the real scope and intent of the act, it may be well to quote those parts of it that have relation to the subject matter of this prosecution.

Section 1 of the act provides, “that no person shall, within the District of Columbia, by himself or by his servant or agent, or as the servant or agent of any other person, sell, exchange or deliver, or have in his custody or possession with the intent to sell or exchange, any article of food or drug which is adulterated within the meaning of this [88]*88act.” This provision, as will be observed, is positive in its terms.

Section 2 declares, “that the term 'drug’ as used in this act, shall include all medicines for external or internal use, antiseptics, disenfectants and cosmetics.”

And by section 3 it is provided, “ that an article shall be deemed to be adulterated within the meaning of this act: (a) In the case of drugs: First, if, when sold under or by a name recognized in the United States pharmacopoeia, it differs from the standard of strength, quality or purity laid down in the edition thereof at the time official; second, if, when sold under or by a name not recognized in the United States pharmacopoeia, but which is found in the German, French or English pharmacopoeia, it differs from the strength, quality or purity laid down therein; third, if, when sold as a patented medicine, compounded drug or mixture, it is not composed of all the ingredients advertised or printed or written on the bottle, wrapper or labels of or on or with the patented medicine, compounded drug or mixture: Provided, that if the defendant in any prosecution under this act, in respect to the sale of any such patented medicine, compounded drug or mixture, shall prove to the satisfaction of the court that he had purchased the article in question as the same in nature, substance and purity as that demanded of him by the purchaser, and with a written warranty to that effect; that he had no reason to believe at the time when he sold it that the article was otherwise, and that he sold it in the same state as when he purchased it, he shall be discharged from the prosecution.”

The Hoffman .Anodyne, it appears, is recognized and described in the United States pharmacopoeia, and is not of the third class and description of medicines and compounds referred to in the third section of the act of Congress; nor did the defendant attempt to make and establish the defense as provided in the proviso to the third section of the act may be done, “ in respect to the sale of any such patented medicine, compounded drug or mixture.”

[89]*89In the trial of a prosecution under this statute, it is incumbent upon the District of Columbia, in whose name the prosecution is conducted, to prove the sale and delivery of the medicine or drug by the defendant, or his possession thereof for purpose of sale, and that the same was adulterated within the meaning of the statute. The prosecution upon such proof makes out a prima facie case of guilt against the defendant; and it is no defense for the defendant to show simply that he was at the time of sale, or of possession for sale, ignorant of the fact of such adulteration of the drug or medicine. He must know what he sells or proposes to sell, and that it conforms to the standard prescribed by law.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

People v. . Kibler
12 N.E. 795 (New York Court of Appeals, 1887)
People v. . Cipperly
4 N.E. 107 (New York Court of Appeals, 1886)
Commonwealth v. Smith
103 Mass. 444 (Massachusetts Supreme Judicial Court, 1869)
Commonwealth v. Gray
23 N.E. 47 (Massachusetts Supreme Judicial Court, 1889)
Commonwealth v. Warren
36 N.E. 308 (Massachusetts Supreme Judicial Court, 1894)
Smith v. Hays
23 Ill. App. 244 (Appellate Court of Illinois, 1887)
Brown v. Marshall
11 N.W. 392 (Michigan Supreme Court, 1882)
People v. Roby
18 N.W. 365 (Michigan Supreme Court, 1884)

Cite This Page — Counsel Stack

Bluebook (online)
16 App. D.C. 85, 1900 U.S. App. LEXIS 5275, Counsel Stack Legal Research, https://law.counselstack.com/opinion/district-of-columbia-v-lynham-cadc-1900.